Toxic metabolites, MAPK and Nrf2/Keap1 signaling pathways involved in oxidative toxicity in mice liver after chronic exposure to Mequindox

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Liu, Qianying ^a   Lei, Zhixin ^a   Huang, Anxiong ^a   Wu, Qinghua ^b,c   Xie, Shuyu ^d   Awais, Ihsan ^e   Dai, Menghong ^a   Wang, Xu ^a   Yuan, Zonghui ^a,d  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b YANGTZE UNIVERSITY   (China)

^c UNIVERSITY OF HRADEC KRALOVE   (Czech Republic)

^d Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety   (China)

^e COMSATS Institute of Information Technology ^*  (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; KEAP1 PROTEIN, MOUSE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MEQUINDOX; NFE2L2 PROTEIN, MOUSE; QUINOXALINE DERIVATIVE; TRANSCRIPTION FACTOR NRF2;

ANIMAL; DRUG EFFECT; FEMALE; LIVER; MALE; MAPK SIGNALING; METABOLISM; MOUSE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS;

ANIMALS; ANTI-INFECTIVE AGENTS; FEMALE; KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; LIVER; MALE; MAP KINASE SIGNALING SYSTEM; MICE; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; OXIDATIVE STRESS; QUINOXALINES;

EID: 85011588248     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep41854     Document Type: Article

References (74)

1. Cheng, G. et al. Systematic and Molecular Basis of the Antibacterial Action of Quinoxaline 1,4-Di-N-Oxides against Escherichia coli. Plos one 10, e0136450 (2015).
2. Liu, Q. Y. et al. Further investigations into the genotoxicity of quinoxaline-di-N-oxides and their primary metabolites. Food Chem Toxicol 93, 145-157 (2016).
3. Vicente, E. et al. Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides. Bioorgan Med Chem 17, 385-389 (2009).
4. Wang, X. et al. Two generation reproduction and teratogenicity studies of feeding cyadox in Wistar rats. Food Chem Toxicol 49, 1068-1079 (2011).
5. Wang, X. et al. Genotoxic risk of quinocetone and its possible mechanism in in-vitro studies. Toxicol Res, doi: 10.1039/C1035TX00341E (2015).
6. Wang, X. et al. Deoxidation rates play a critical role in DNA damage mediated by important synthetic drugs, quinoxaline 1,4-dioxides. Chem Res Toxicol 28, 470-481 (2015).
7. Wu, Y. et al. Development of a high-performance liquid chromatography method for the simultaneous quantification of quinoxaline- 2-carboxylic acid and methyl-3-quinoxaline-2-carboxylic acid in animal tissues. J Chromatogr A 1146, 1-7 (2007).
8. Zhang, K. et al. Investigation of quinocetone-induced mitochondrial damage and apoptosis in HepG2 cells and compared with its metabolites. Environ Toxicol Pha 39, 555-567 (2015).
9. Carta, A., Corona, P. & Loriga, M. Quinoxaline 1,4-dioxide: a versatile scaffold endowed with manifold activities. Curr Med Chem 12, 2259-2272 (2005).
10. Chen, Q. et al. Investigation of the genotoxicity of quinocetone, carbadox and olaquindox in vitro using Vero cells. Food Chem Toxicol 47, 328-334 (2009).
11. Ihsan, A. et al. Acute and subchronic toxicological evaluation of Mequindox in Wistar rats. Regul Toxicol Phar 57, 307-314 (2010).
12. Ihsan, A. et al. Long-term mequindox treatment induced endocrine and reproductive toxicity via oxidative stress in male Wistar rats. Toxicol Appl Pharm 252, 281-288 (2011).
13. Ihsan, A. et al. Genotoxicity of quinocetone, cyadox and olaquindox in vitro and in vivo. Food Chem Toxicol 59, 207-214 (2013).
14. Huang, L. et al. Metabolism, Distribution, and Elimination of Mequindox in Pigs, Chickens, and Rats. J Agri Food Chem 63, 9839-9849 (2015).
15. Cheng, G. et al. Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of Actions. Front Pharmacol 7, 64 (2016).
16. Chen, Q. et al. Characterization of carbadox-induced mutagenesis using a shuttle vector PSP189 in mammalian cells. Mutat Res 638, 11-16 (2008).
17. Hao, L., Chen, Q. & Xiao, X. 2006. Molecular mechanism of mutagenesis induced by olaquindox using a shuttle vector pSP189/mammalian cell system. Mutat Res 599, 21-25 (2006).
18. Ganley, B., Chowdhury, G., Bhansali, J., Daniels, J. S. & Gates, K. S. Redox-activated, hypoxia-selective DNA cleavage by quinoxaline 1,4-di-N-oxide. Bioorgan Med Chem 9, 2395-2401 (2001).
19. Zhang, K. et al. Cytotoxicity and genotoxicity of 1,4-bisdesoxyquinocetone, 3-methyl-quinoxaline-2-carboxylic acid (MQCA) in human hepatocytes. Res Vet Sci 93, 1393-1401 (2012).
20. Ihsan, A. et al. Genotoxicity evaluation of Mequindox in different short-term tests. Food Chem Toxicol 51, 330-336 (2013).
21. Wang, X. et al. Metabolites and JAK/STAT pathway were involved in the liver and spleen damage in male Wistar rats fed with mequindox. Toxicology 280, 126-134 (2011).
22. Azqueta, A. et al. A quinoxaline 1,4-di-N-oxide derivative induces DNA oxidative damage not attenuated by vitamin C and E treatment. Chemico-biol Interact 168, 95-105 (2007).
23. Chowdhury, G., Kotandeniya, D., Daniels, J. S., Barnes, C. L. & Gates, K. S. Enzyme-activated, hypoxia-selective DNA damage by 3-amino-2 quinoxalinecarbonitrile 1,4-di-N-oxide. Chem Res Toxicol 17, 1399-1405 (2004).
24. Wang, X. et al. Fumonisins: oxidative stress-mediated toxicity and metabolism in vivo and in vitro. Arch Toxicol, doi: 10.1007/s00204-00015-01604-00208 (2015).
25. Liu, J. et al. Mequindox induced cellular DNA damage via generation of reactive oxygen species. Mutat Res 741, 70-75 (2012).
26. Huang, X. J. et al. ROS mediated cytotoxicity of porcine adrenocortical cells induced by QdNOs derivatives in vitro. Chem-biol Interact 185, 227-234 (2010).
27. Zou, J. et al. Olaquindox-induced genotoxicity and oxidative DNA damage in human hepatoma G2 (HepG2) cells. Mutat Res 676, 27-33 (2009).
28. Wang, X. et al. High risk of adrenal toxicity of N1-desoxy quinoxaline 1,4-dioxide derivatives and the protection of oligomeric proanthocyanidins (OPC) in the inhibition of the expression of aldosterone synthetase in H295R cells. Toxicol 341-343, 1-16 (2016).
29. Huang, X. J. et al. Long-term dose-dependent response of Mequindox on aldosterone, corticosterone and five steroidogenic enzyme mRNAs in the adrenal of male rats. Toxicol Lett 191, 167-173 (2009).
30. Gong, X., Ivanov, V. N. & Hei, T. K. 2,3,5,6-Tetramethylpyrazine (TMP) down-regulated arsenic-induced heme oxygenase-1 and ARS2 expression by inhibiting Nrf2, NF-kappaB, AP-1 and MAPK pathways in human proximal tubular cells. Arch Toxicol 90, 2187-200 (2015).
31. Kim, H. G. et al. Endosulfan induces COX-2 expression via NADPH oxidase and the ROS, MAPK, and Akt pathways. Arch Toxicol 89, 2039-2050 (2015).
32. Liao, Y. C., Chen, Y. F. & Lee, T. C. Increased susceptibility of H-Ras(G12V)-transformed human urothelial cells to the genotoxic effects of sodium arsenite. Arch Toxicol 89, 1971-1979 (2015).
33. Romanov, V., Whyard, T. C., Waltzer, W. C., Grollman, A. P. & Rosenquist, T. Aristolochic acid-induced apoptosis and G2 cell cycle arrest depends on ROS generation and MAP kinases activation. Arch Toxicol 89, 47-56 (2015).
34. Wang, X. et al. The critical role of oxidative stress in the toxicity and metabolism of quinoxaline 1,4-di-N-oxides in vitro and in vivo. Drug Metab Rev 48, 159-182 (2016).
35. Watanabe, T., Sekine, S., Naguro, I., Sekine, Y. & Ichijo, H. Apoptosis Signal-regulating Kinase 1 (ASK1)-p38 Pathway-dependent Cytoplasmic Translocation of the Orphan Nuclear Receptor NR4A2 Is Required for Oxidative Stress-induced Necrosis. J Biol Chem 290, 10791-10803 (2015).
36. Ze, Y. et al. Molecular mechanism of titanium dioxide nanoparticles-induced oxidative injury in the brain of mice. Chemosphere 92, 1183-1189 (2013).
37. Paradies, G., Petrosillo, G., Pistolese, M. & Ruggiero, F. M. The effect of reactive oxygen species generated from the mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles. FEBS lett 466, 323-326 (2000).
38. Kimura, M. et al. Molecular basis distinguishing the DNA binding profile of Nrf2-Maf heterodimer from that of Maf homodimer. J Biol Chem 282, 33681-33690 (2007).
39. Kobayashi, M. & Yamamoto, M. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Sign 7, 385-394 (2005).
40. Li, W. & Kong, A. N. Molecular mechanisms of Nrf2-mediated antioxidant response. Mole Carcinogen 48, 91-104 (2009).
41. Pedruzzi, L. M., Stockler-Pinto, M. B., Leite, M. & Mafra, D. Jr. Nrf2-keap1 system versus NF-kappaB: the good and the evil in chronic kidney disease? Biochimie 94, 2461-2466 (2012).
42. Lee, S. E. et al. Induction of heme oxygenase-1 inhibits cell death in crotonaldehyde-stimulated HepG2 cells via the PKC-delta-p38-Nrf2 pathway. Plos one 7, e41676 (2012).
43. Yang, C. M., Huang, S. M., Liu, C. L. & Hu, M. L. Apo-8′ -lycopenal induces expression of HO-1 and NQO-1 via the ERK/p38-Nrf2-ARE pathway in human HepG2 cells. J Agr Food Chem 60, 1576-1585 (2012).
44. Zhao, D. X. et al. Reactive oxygen species-dependent JNK downregulated olaquindox-induced autophagy in HepG2 cells. J Appl Toxicol 35, 709-716 (2015).
45. Zhao, W. X. et al. Olaquindox-induced apoptosis is suppressed through p38 MAPK and ROS-mediated JNK pathways in HepG2 cells. Cell Biol Toxicol 29, 229-238 (2013).
46. Yang, W. et al. Quinocetone triggers oxidative stress and induces cytotoxicity and genotoxicity in human peripheral lymphocytes of both genders. J Sci Food Agr 93, 1317-1325 (2013).
47. Yu, M. et al. Nrf2/ARE is the potential pathway to protect Sprague-Dawley rats against oxidative stress induced by quinocetone. Regul Toxicol Pharm 66, 279-285 (2013).
48. Wang, X. et al. Genomic and proteomic analysis of the inhibition of synthesis and secretion of aldosterone hormone induced by quinocetone in NCI-H295R cells. Toxicology 350-352, 1-14 (2016).
49. Wang, X. et al. A chronic toxicity study of cyadox in Wistar rats. Regul. Toxicol. Phar. 59, 324-333 (2011).
50. Wang, X. et al. Acute and sub-chronic oral toxicological evaluations of quinocetone in Wistar rats. Regul Toxicol Phar 58, 421-427 (2010).
51. Wang, X. et al. Mechanism of adrenocortical toxicity induced by quinocetone and its bidesoxy quinocetone metabolite in porcine adrenocortical cells in vitro. Food Chem Toxicol 84, 115-124 (2015).
52. Zhang, K. et al. Identification of oxidative stress and responsive genes of HepG2 cells exposed to quinocetone, and compared with its metabolites. Cell Biol Toxicol 30, 313-329 (2014).
53. Dai, C., Tang, S., Li, D., Zhao, K. & Xiao, X. Curcumin attenuates quinocetone-induced oxidative stress and genotoxicity in human hepatocyte L02 cells. Toxicol Mech Method 25, 340-346 (2015).
54. Li, Z. et al. Research on olaquindox induced endoplasmic reticulum stress related apoptosis on nephrotoxicity. J Hygi Res 44, 444-450 (2015).
55. Zhang, C. M. et al. TNFR1/TNF-alpha and mitochondria interrelated signaling pathway mediates quinocetone-induced apoptosis in HepG2 cells. Food Chem Toxicol 62, 825-838 (2013).
56. Zhang, T. et al. c-Myc influences olaquindox-induced apoptosis in human hepatoma G2 cells. Mol Cell Biochem 354, 253-261 (2011).
57. Zou, J. et al. Olaquindox induces apoptosis through the mitochondrial pathway in HepG2 cells. Toxicol 285, 104-113 (2011).
58. Huang, X. J. et al. Interactions of NADPH oxidase, renin-angiotensin-aldosterone system and reactive oxygen species in mequindoxmediated aldosterone secretion in Wistar rats. Toxicol Lett 198, 112-118 (2010).
59. Yu, M. et al. Quinocetone-induced Nrf2/HO-1 pathway suppression aggravates hepatocyte damage of Sprague-Dawley rats. Food Chem Toxicol 69, 210-219 (2014).
60. Wang, D. et al. Pu-erh black tea supplementation decreases quinocetone-induced ROS generation and oxidative DNA damage in Balb/c mice. Food Chem Toxicol 49, 477-484 (2011).
61. Zhao, X. J. et al. Dynamic metabolic response of mice to acute mequindox exposure. J Proteome 10, Res, 5183-5190 (2011).
62. Liu, Z. Y., Huang, L. L., Chen, D. M. & Yuan, Z. H. Metabolism of mequindox in liver microsomes of rats, chicken and pigs. Rapid Commun Mass 24, 909-918 (2010).
63. Junnotula, V., Sarkar, U., Sinha, S. & Gates, K. S. Initiation of DNA strand cleavage by 1,2,4-benzotriazine 1,4-dioxide antitumor agents: mechanistic insight from studies of 3-methyl-1,2,4-benzotriazine 1,4-dioxide. J Am Chem Soc 131, 1015-1024 (2009).
64. Poole, J. S. et al. Photochemical electron transfer reactions of tirapazamine. J Photoch Photobio 75, 339-345 (2002).
65. El-Khatib, M., Geara, F., Haddadin, M. J. & Gali-Muhtasib, H. Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21. Radiat Oncol, doi: 10.1186/1748-717X-5-107 (2010).
66. Yang, H. Y. & Lee, T. H. Antioxidant enzymes as redox-based biomarkers: a brief review. BMB Rep 48, 200-208 (2015).
67. Shi, J. et al. Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation. Tumour Biol 36, 655-662 (2015).
68. Liu, Z. Y. & Sun, Z. L. The metabolism of carbadox, olaquindox, mequindox, quinocetone and cyadox: an overview. J Med Chem 9, 1017-1027 (2013).
69. Prasad, S., Ravindran, J. & Aggarwal, B. B. NF-kappaB and cancer: how intimate is this relationship. Mol Cell Biochem 336, 25-37 (2010).
70. Gui, S. et al. Renal injury and Nrf2 modulation in mouse kidney following chronic exposure to TiO(2) nanoparticles. J Agri Food Chem 61, 8959-8968 (2013).
71. Luo, L. et al. Butylated hydroxyanisole induces distinct expression patterns of Nrf2 and detoxification enzymes in the liver and small intestine of C57BL/6 mice. Toxicol Appl Pharm 288, 339-348 (2015).
72. NRC. The Development of Science based Guidelines for Laboratory Animal Care, Proceedings of the November 2003 International Workshop. National Academy Press, Washington, DC (2004).
73. Yang, Y. et al. Olaquindox induces DNA damage via the lysosomal and mitochondrial pathway involving ROS production and p53 activation in HEK293 cells. Environ Toxicol Pha 40, 792-799 (2015).
74. Sánchez-Gómez, F. J. et al. Detoxifying Enzymes at the Cross-Roads of Inflammation, Oxidative Stress, and Drug Hypersensitivity: Role of Glutathione Transferase P1-1 and Aldose Reductase. Front Pharmacol 7, 237 (2016).